Brief Report
Copyright ©The Author(s) 1996.
World J Gastroenterol. Sep 15, 1996; 2(3): 185-186
Published online Sep 15, 1996. doi: 10.3748/wjg.v2.i3.185
Table 1 Comparison serum alpha-fetoprotein, carbohydrate antibody19-9 and carcinoembryonic antigen in patients with hepatic solid space occupying lesions (x-± s)
GroupingnAFP (μg/L)CA19-9 (KU/L)CEA (μg/L)
1 BHSSOL3011.07 ± 4.3028.43 ± 15.7610.49 ± 6.93
2 SHC3015.23 ± 13.13231.20 ± 196.6427.08 ± 13.35
3 PNHCC3014.03 ± 8.13169.67 ± 140.0819.27 ± 8.67
4 PHCC30320.65 ± 180.1223.73 ± 12.9110.73 ± 3.94
Notes: The comparison of AFP levels between group 4 and groups 1, 2, and 3: P < 0.01; among groups 1, 2, and 3: P > 0.05. CA 19-9 levels in groups 2 and 3 were higher than those in groups 1 and 4: P < 0.01; between group 2 and 3 and between group 1 and 4: P > 0.05. CEA levels in groups 2 and 3 were higher than those in groups 1 and 4 (P < 0.01); between group 2 and 3 and between group 1 and 4: P > 0.05. AFP, alpha-fetoprotein; BHSSOL, benign HSSOL; CA19-9, carbohydrate antibody 19-9; CEA, carcinoembryonic antigen; HSSOL, hepatic solid space occupying lesion; PHCC, primary hepatocellular carcinoma; PNHCC, primary non-hepatocellular carcinoma; SHC, secondary hepatic carcinoma